DPG Mitgliedschaft

This block is broken or missing. You may be missing content or you might need to enable the original module.

Keyword: Celgene

News

FTC Approves $74 Billion BMS-Celgene Deal

20.11.2019 - The US Federal Trade Commission has approved Bristol-Myers Squibb’s $74 billion takeover of biotech Celgene by a vote of 3 to 2. The biggest merger in the history of the global...

Markets & Companies

Injecting Growth and Innovation

13.09.2019 - Abbvie takes over Allergan, Pfizer merges its generics business with Mylan, Takeda integrates Shire — the pharmaceutical industry is making a name for itself in 2019 with several...

News

BMS Shareholders Greenlight Celgene Deal

17.04.2019 - Shareholders of Bristol Myers Squibb (BMS) have approved the company’s $74 billion acquisition of Celgene. At the special meeting on Apr. 12, altogether 75% of the shareholders...

Strategy & Management

The Need for Innovation in Pharmaceutical Manufacturing

08.04.2019 - The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious...

News

Starboard Backs Away from BMS-Celgene Bust-up

02.04.2019 - Activist investor Starboard Value has backed away from plans to torpedo the proposed $74 billion merger of Bristol-Myers Squibb with Celgene after independent proxy advisory firms...

News

BMS Shareholders Fight Celgene Takeover

01.03.2019 - Activist investor Starboard Value, which very recently bought a 1 million share in Bristol-Myers Squibb (BMS) and nominated five directors to the board, has now made public its...

News

Celgene Wins Patent Row, Gets Generic Rival

18.02.2019 - Within a week, US biotech Celgene, which is in the process of being acquired by Bristol-Myers-Squibb (BMS), dodged a challenge to its patent for the blockbuster multiple myeloma...

News

BMS-Celgene Deal May be in Danger

05.02.2019 - The proposed $74 billion takeover of US biotech Celgene by compatriot BristolMyers Squibb (BMS), announced last month, may be looking somewhat shaky. Analysts and investors up to...

Ehrenamtliches Engagement

This block is broken or missing. You may be missing content or you might need to enable the original module.

Social Media

LinkedIn | Twitter

Subscribe to our Newsletter!

Newsletter

We keep you posted - Subscribe to the CHEManager International newsletter here!

Social Media

LinkedIn | Twitter

Subscribe to our Newsletter!

Newsletter

We keep you posted - Subscribe to the CHEManager International newsletter here!